These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17132090)

  • 1. Characterization of frequently deleted 6q locus in prostate cancer.
    Sun M; Srikantan V; Ma L; Li J; Zhang W; Petrovics G; Makarem M; Strovel JW; Horrigan SG; Augustus M; Sesterhenn IA; Moul JW; Chandrasekharappa S; Zou Z; Srivastava S
    DNA Cell Biol; 2006 Nov; 25(11):597-607. PubMed ID: 17132090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss on chromosome 6Q in primary prostate cancer.
    Srikantan V; Sesterhenn IA; Davis L; Hankins GR; Avallone FA; Livezey JR; Connelly R; Mostofi FK; McLeod DG; Moul JW; Chandrasekharappa SC; Srivastava S
    Int J Cancer; 1999 Jun; 84(3):331-5. PubMed ID: 10371356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of proximal 6q deletions in prostate cancer.
    Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
    Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
    Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
    Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression mapping at 12p12-13 in advanced prostate carcinoma.
    Kibel AS; Huagen J; Guo C; Isaacs WB; Yan Y; Pienta KJ; Goodfellow PJ
    Int J Cancer; 2004 May; 109(5):668-72. PubMed ID: 14999772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of chromosomal region 6q14-16 in prostate cancer.
    Verhagen PC; Hermans KG; Brok MO; van Weerden WM; Tilanus MG; de Weger RA; Boon TA; Trapman J
    Int J Cancer; 2002 Nov; 102(2):142-7. PubMed ID: 12385009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
    Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
    Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.
    Sinclair PB; Sorour A; Martineau M; Harrison CJ; Mitchell WA; O'Neill E; Foroni L
    Cancer Res; 2004 Jun; 64(12):4089-98. PubMed ID: 15205317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
    Lu X; Guo J; Hsieh TC; Wu JM
    Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
    Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
    Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
    Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
    Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
    Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
    Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.